The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
Open accessAbstract
BACKGROUND: The RTS,S/AS01 vaccine targets the circumsporozoite protein of Plasmodium falciparum and has partial protective efficacy against clinical and severe malaria disease in infants and children. We investigated whether the vaccine efficacy was specific to certain parasite genotypes at the circumsporozoite protein locus. METHODS: We used polymerase chain reaction-based next-generation sequencing of DNA extracted from samples from 4985 participants to survey circumsporozoite protein polymorphisms. We evaluated the effect that polymorphic positions and haplotypic regions within the circumsporozoite protein had on vaccine efficacy against first episodes of clinical malaria within 1 year after vaccination. RESULTS: In the per-protocol group of 4577 RTS,S/AS01-vaccinated participants and 2335 control-vaccinated participants who were 5 to 17 months of age, the 1-year cumulative vaccine efficacy was 50.3% (95% confidence interval [CI], 34.6 to 62.3) against clinical malaria in which parasites matched the vaccine in the entire circumsporozoite protein C-terminal (139 infections), as compared with 33.4% (95% CI, 29.3 to 37.2) against mismatched malaria (1951 infections) (P=0.04 for differential vaccine efficacy). The vaccine efficacy based on the hazard ratio was 62.7% (95% CI, 51.6 to 71.3) against matched infections versus 54.2% (95% CI, 49.9 to 58.1) against mismatched infections (P=0.06). In the group of infants 6 to 12 weeks of age, there was no evidence of differential allele-specific vaccine efficacy. CONCLUSIONS: These results suggest that among children 5 to 17 months of age, the RTS,S vaccine has greater activity against malaria parasites with the matched circumsporozoite protein allele than against mismatched malaria. The overall vaccine efficacy in this age category will depend on the proportion of matched alleles in the local parasite population; in this trial, less than 10% of parasites had matched alleles. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Applying Cox Regression to Competing Risks
Lunn, M., & McNeil, D. (1995) · Biometrics · doi:10.2307/2532940 · Cited by 975
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
The RTS, S. C. T. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102287 · Cited by 896
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
The RTS, S. C. T. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208394 · Cited by 752
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Self-citationBache, E. B., Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Kabwende, A. L., Adégnika, A. A., Mordmüller, B. G., Kremsner, P. G., Loembé, M. M., et al. (2015) · The Lancet · doi:10.15496/publikation-6508 · Cited by 642
Self-citationKester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
Self-citationThe RTS, S. C. T. P. (. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001685 · Cited by 474
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
Self-citationA Field Trial to Assess a Blood-Stage Malaria Vaccine
Thera, M. A., Doumbo, O. K., Coulibaly, D., Laurens, M. B., Ouattara, A., Kone, A. K., Guindo, A. B., Traore, K., Traore, I., Kouriba, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008115 · Cited by 370
Aponte, J. J., Aide, P., Renom, M., Mandomando, I., Bassat, Q., Sacarlal, J., Manaca, M. N., Lafuente, S., Barbosa, A., Leach, A., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61542-6 · Cited by 279
Self-citationReece, W. H. H., Pinder, M., Gothard, P. K., Milligan, P., Bojang, K., Doherty, T., Plebanski, M., Akinwunmi, P., Everaere, S., Watkins, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1009 · Cited by 264
Self-citationSafety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Abdulla, S., Oberholzer, R., Juma, O., Kubhoja, S., Machera, F., Membi, C., Omari, S., Urassa, A., Mshinda, H., Jumanne, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807773 · Cited by 239
Self-citationSun, P., Schwenk, R., White, K., Stoute, J. A., Cohen, J., Ballou, W. R., Voss, G., Kester, K. E., Heppner, D. G., & Krzych, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6961 · Cited by 232
Asante, K. P., Abdulla, S., Agnandji, S. T., Lyimo, J., Vekemans, J., Soulanoudjingar, S., Owusu, R., Shomari, M., Leach, A. J., Jongert, E., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70100-1 · Cited by 175
Self-citationLalvani, A., Moris, P., Voss, G., Pathan, A. A., Kester, K. E., Brookes, R. H., Lee, E., Koutsoukos, M., Plebanski, M., Delchambre, M., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315074 · Cited by 155
Follmann, D. A., Proschan, M. A., & Leifer, E. (2003) · Biometrics · doi:10.1111/1541-0420.00049 · Cited by 116
Agnandji, S. T., Asante, K. P., Lyimo, J., Vekemans, J., Soulanoudjingar, S., Owusu, R., Shomari, M., Leach, A. J., Fernandes, J. F., Dosoo, D., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656190 · Cited by 108
Self-citationPROTECTIVE EFFICACY OF THE RTS,S/AS02 PLASMODIUM FALCIPARUM MALARIA VACCINE IS NOT STRAIN SPECIFIC
Alloueche, A., Milligan, P. J., Conway, D. J., Pinder, M., Bojang, K., Doherty, T., Tornieporth, N., Cohen, J., & Greenwood, B. M. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.97 · Cited by 87
Self-citationEnosse, S. M., Dobaño, C., Quelhas, D., Aponte, J. J., Lievens, M., Leach, A. J., Sacarlal, J., Greenwood, B. M., Milman, J., Dubovsky, F., et al. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010005 · Cited by 77
Self-citationBailey, J. A., Mvalo, T., Aragam, N., Weiser, M., Congdon, S., Kamwendo, D., Martinson, F. E. A., Hoffman, I., Meshnick, S. R., & Juliano, J. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis329 · Cited by 63
Self-citationWaitumbi, J. N., Anyona, S. B., W., H., Kifude, C., Polhemus, M. E., Walsh, D. S., Ockenhouse, C. F., Heppner, D. G., Leach, A. J., Lievens, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007849 · Cited by 59
Self-citationAíde, P., Dobaño, C., Sacarlal, J., Aponte, J. J., Mandomando, I., Guinovart, C., Bassat, Q., Renom, M., Puyol, L., Macete, E., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.041 · Cited by 58
Self-citationMalaria Control, Elimination, and Eradication: The Role of the Evolving Biomedical Research Agenda
Hall, B., & Fauci, A. S. (2009) · The Journal of Infectious Diseases · doi:10.1086/646611 · Cited by 42
Campo, J. J., Aponte, J. J., Skinner, J., Nakajima, R., Molina, D. M., Liang, L., Sacarlal, J., Alonso, P. L., Crompton, P. D., Felgner, P. L., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.044677 · Cited by 40
Self-citationVariation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
Gandhi, K., Thera, M. A., Coulibaly, D. M., Traoré, K., Guindo, A. B., Ouattara, A., Takala‐Harrison, S., Berry, A. A., Doumbo, O. K., & Plowe, C. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101783 · Cited by 37
Next Generation Sequencing to Detect Variation in the Plasmodium falciparum Circumsporozoite Protein
Gandhi, K., Thera, M. A., Coulibaly, D. M., Traoré, K., Guindo, A. B., Doumbo, O. K., Takala‐Harrison, S., & Plowe, C. V. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0478 · Cited by 36
Aragam, N., Thayer, K. M., Nge, N. M., Hoffman, I., Martinson, F. E. A., Kamwendo, D., Lin, F., Sutherland, C. J., Bailey, J. A., & Juliano, J. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062427 · Cited by 24
Self-citation
Cited by
Ashley, E. A., Pyae Phyo, A., & Woodrow, C. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30324-6 · Cited by 553
RTS,S/AS01 vaccine (Mosquirix™): an overview
Laurens, M. B. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1669415 · Cited by 491
Malaria eradication within a generation: ambitious, achievable, and necessary
Feachem, R. G. A., Chen, I., Akbari, O., Bertozzi-Villa, A., Bhatt, S., Binka, F., Boni, M. F., Buckee, C., Dieleman, J., Dondorp, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31139-0 · Cited by 366
Malaria Vaccines: Recent Advances and New Horizons
Draper, S. J., Sack, B. K., King, C. R., Nielsen, C. M., Rayner, J. C., Higgins, M. K., Long, C. A., & Seder, R. A. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.008 · Cited by 331
Malaria vaccines since 2000: progress, priorities, products
Duffy, P. E., & Patrick Gorres, J. (2020) · npj Vaccines · doi:10.1038/s41541-020-0196-3 · Cited by 266
Metadata
- Authors
- Neafsey, D. E., Juraska, M., Bedford, T., Benkeser, D., Valim, C., Griggs, A., Lievens, M., Abdulla, S., Adjei, S., Agbenyega, T., Agnandji, S. T., Aide, P., Anderson, S., Ansong, D., Aponte, J. J., Asante, K. P., Bejon, P., Birkett, A. J., Bruls, M., Connolly, K. M., D’Alessandro, U., Dobaño, C., Gesase, S., Greenwood, B., Grimsby, J., Tinto, H., Hamel, M. J., Hoffman, I., Kamthunzi, P., Kariuki, S., Kremsner, P. G., Leach, A., Lell, B., Lennon, N. J., Lusingu, J., Marsh, K., Martinson, F., Molel, J. T., Moss, E. L., Njuguna, P., Ockenhouse, C. F., Ogutu, B. R., Otieno, W., Otieno, L., Otieno, K., Owusu-Agyei, S., Park, D. J., Pellé, K., Robbins, D., Russ, C., Ryan, E. M., Sacarlal, J., Sogoloff, B., Sorgho, H., Tanner, M., Theander, T., Valea, I., Volkman, S. K., Yu, Q., Lapierre, D., Birren, B. W., Gilbert, P. B., & Wirth, D. F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-11-19
- Volume
- 373
- Issue
- 21
- Pages
- 2025-2037
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2289977218
- Cited by
- 422
- References
- 31
- FWCI
- 36.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.